HT
AVDL

HAP Trading’s Avadel Pharmaceuticals AVDL Stock Holding History

HAP Trading’s Portfolio AVDL Stock Details AVDL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-11,900
Closed -$6K – 1099
2023
Q1 		$6K Sell
11,900
-14,700
-55% -$121K ﹤0.01% 963
2022
Q4 		$21K Buy
26,600
+9,300
+54% +$65.2K ﹤0.01% 944
2022
Q3 		$10K Buy
17,300
+1,000
+6% +$5.5K ﹤0.01% 1321
2022
Q2 		$2K Sell
16,300
-10,500
-39% -$43.1K ﹤0.01% 1756
2022
Q1 		$19K Buy
26,800
+7,800
+41% +$53.6K ﹤0.01% 1582
2021
Q4 		$10K Buy
+19,000
New +$174K ﹤0.01% 2046
2021
Q3 		– Sell
-11,100
Closed -$2K – 2430
2021
Q2 		$2K Sell
11,100
-6,800
-38% -$54K ﹤0.01% 2245
2021
Q1 		$7K Buy
+17,900
New +$145K ﹤0.01% 1691
2020
Q4 		– Sell
-12,200
Closed -$3K – 2195
2020
Q3 		$3K Sell
12,200
-9,700
-44% -$70.6K ﹤0.01% 1476
2020
Q2 		$12K Sell
21,900
-343,900
-94% -$3.03M ﹤0.01% 1411
2020
Q1 		$748K Buy
+365,800
New +$2.81M 0.05% 274

Other funds holding AVDL

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
GJL
Gendell Jeffrey L $7.34B AUM 183.72% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
WE
Wealth Effects Boston, Massachusetts $282M AUM 62.81% 1-Year Est. Return

HAP Trading's AVDL Position: Q3 2025 in Review

HAP Trading increased its Avadel Pharmaceuticals (AVDL) stake by 61% in Q3 2025, buying an estimated $340K and bringing the position to 68,962 shares worth $1.05M. The position accounts for 0.07% of the portfolio, ranked #172.

HAP Trading first reported a position in AVDL in Q1 2025 and has held it in 3 quarters since. 188 funds tracked by Wall St. Rank hold AVDL as of Q3 2025.

  • HAP Trading held 68,962 shares of Avadel Pharmaceuticals worth $1.05M as of Q3 2025.
  • HAP Trading bought 26,130 Avadel Pharmaceuticals shares in Q3 2025, an estimated $340K.
  • Avadel Pharmaceuticals made up 0.07% of HAP Trading's portfolio in Q3 2025, its #172 holding.
  • HAP Trading first reported a position in Avadel Pharmaceuticals in Q1 2025 and has held it in 3 quarters since.
  • 188 funds tracked by Wall St. Rank held Avadel Pharmaceuticals as of Q3 2025.

Based on HAP Trading's 13F filing for Q3 2025, filed 12 Nov 2025.